The Massachusetts pharmacy that supplied a back-pain steroid treatment blamed for a deadly nationwide meningitis outbreak isn't licensed to distribute the drug in Minnesota, the Associated Press reports. About 120 people have been sickened by the outbreak nationwide, including three in Minnesota, and 12 have died.

The Health Department now says three Minnesota women in their 40s are hospitalized with the rare form of fungal meningitis linked to injections of a steroid provided by a Massachusetts lab. That lab recalled all of its products over the weekend. Nationwide the outbreak includes more than 90 people, seven of whom have died.

Health officials have confirmed three cases of fungal meningitis in Minnesota, while hundreds of other patients who were injected with a recalled steroid are being tested. An executive with one of the clinics that dispensed the steroid says officials are reassuring patients while also arranging tests for those who need them. Nationwide, the death toll in the fungal meningitis outbreak has reached 11, with the number of cases over 100.

Doctors have diagnosed two Minnesota women, both in their 40s, with meningitis after they received injectable steroids from a Massachusetts pharmacy, the Minnesota Department of Health said in a news release Saturday. Officials expect to see more cases in the state as the nearly one thousand patients treated with the tainted products are notified.

A U.S. District Court has ruled competitor NuVasive must pay the Minnesota-based medical device maker more than $100 million in damages for infringing on three of its patents.